Search for:

The Cancer Letter on Facebook
The Cancer Letter on Twitter
The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Search for:

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Clinical

Free TCCL Archive

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

February 03, 2014

Vol.37 No.01

Posts navigation

Previous 1…6263

Trending Stories

Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.”
Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
CBER Director Vinay Prasad dared to “say no to drugs”
Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

ABOUT

About The Cancer Letter

Accessibility Statement

SUBSCRIPTIONS

CONTACT

Submission guidelines

Advertise

Careers

SEE ALSO

Terms & Conditions

Scroll to top

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

SEARCH DATE

SEARCH TEXT

Cancel

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Password

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Username or Email

Password

Remember Me Forgot Password?

Site license subscribers:
Log in with your IP | Register a sponsored account